• Dossia (Cambridge, Massachusetts) said that it has added a variety of new features to the upcoming release of the Dossia Personally Controlled Health Record. These new features include the capability to support personal health records for employees' dependents. Dossia will now provide lifelong personal health records to both employees and their dependents, including adults, children and adolescents. The announcement around Dossia's support of dependent health records is expected to pave the way for accelerated growth in the number of Dossia users. Through Dossia's Web-based infrastructure, employees have access to and control over their lifelong, personal, private and portable health information, and have access to a variety of health tools that allow users to take better control of their health and healthcare.

• eGistics (Dallas) said that Consultants in Radiology, PA (CIRPA), a Texas-based radiology practice led by 14 board-certified physicians, has deployed eGistics' Digital Medical Practice (DMP) solution. The hosted eGistics solution will help CIRPA improve operating efficiency, accelerate document research, and streamline secondary billing. CIRPA said it is deploying the eGistics DMP solution to all of its practice facilities and to the offices of all of its radiology interpretation partners. Built on the eGistics hosted document management platform, DMP enables physician practices to digitize much of their office paperwork, streamline administrative operations, and reduce the costs associated with managing and distributing physical documents. By placing all administrative documents online, practice staff do not waste time trying to locate documents or correspondence, in turn, reducing the time to resolve denied or underpaid claims. In addition, the solution facilitates regulatory compliance by electronically managing credentialing documents. And it ensures disaster recovery and business continuity by storing information online and making it accessible via the web.

• GI Dynamics (Lexington, Massachusetts) reported data which support the safety and efficacy of the EndoBarrier Gastrointestinal Liner for pre-surgical weight loss treatment, along with a positive effect on glucose homeostasis in morbidly obese patients with Type 2 diabetes mellitus. The EndoBarrier Gastrointestinal Liner is placed in the GI tract endoscopically (via the mouth) to create a barrier between food and the wall of the intestine. Physicians believe that preventing food from coming into contact with the intestinal wall may alter the activation of hormonal signals that originate in the intestine, thus mimicking the effects of a Roux-en-Y gastric bypass procedure without surgery. GI Dynamics says a growing body of preclinical and clinical evidence supports the potential for EndoBarrier Gastrointestinal Liner to change the treatment landscape for people living with type 2 diabetes, obese people at risk for Type 2 diabetes, and people with severe weight problems.